Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
Clinical Genetics
|
September 1, 1975
A girl with 46,XX,t(1;15) karyotype. Cytogenetic and clinical observations
J O van Hemel, J P van Biervliet, P W de Jager-van der Grift
Biochimica Et Biophysica Acta
|
August 26, 2004
Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: the importance of synthetic ceramide composition
Miranda W de Jager, Gert S Gooris, Igor P Dolbnya, et al.
Journal of Lipid Research
|
February 18, 2004
Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization
Miranda W de Jager, Gert S Gooris, Igor P Dolbnya, et al.
Chemistry and Physics of Lipids
|
June 24, 2003
The phase behaviour of skin lipid mixtures based on synthetic ceramides
M W de Jager, G S Gooris, I P Dolbnya, et al.
Anesthesiology
|
July 20, 2002
The role of transcranial motor evoked potentials in predicting neurologic and histopathologic outcome after experimental spinal cord ischemia
Jeroen Lips, Peter de Haan, Steven W de Jager, et al.
Journal of Neurosurgical Anesthesiology
|
January 5, 2002
Peri-ischemic aminoguanidine fails to ameliorate neurologic and histopathologic outcome after transient spinal cord ischemia
Jeroen Lips, Steven W de Jager, Peter de Haan, et al.
Diabetologia
|
March 15, 2006
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002
C Herder, J Baumert, B Thorand, et al.
Journal of Neuroimmunology
|
August 24, 2015
Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy
L Vlam, M Stam, W de Jager, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 25, 2011
Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes
A A Verrijn Stuart, H S Schipper, I Tasdelen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 24, 2014
Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis
F Bellutti Enders, F van Wijk, R Scholman, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
Clinical Genetics
|
September 1, 1975
A girl with 46,XX,t(1;15) karyotype. Cytogenetic and clinical observations
J O van Hemel, J P van Biervliet, P W de Jager-van der Grift
Biochimica Et Biophysica Acta
|
August 26, 2004
Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: the importance of synthetic ceramide composition
Miranda W de Jager, Gert S Gooris, Igor P Dolbnya, et al.
Journal of Lipid Research
|
February 18, 2004
Novel lipid mixtures based on synthetic ceramides reproduce the unique stratum corneum lipid organization
Miranda W de Jager, Gert S Gooris, Igor P Dolbnya, et al.
Chemistry and Physics of Lipids
|
June 24, 2003
The phase behaviour of skin lipid mixtures based on synthetic ceramides
M W de Jager, G S Gooris, I P Dolbnya, et al.
Anesthesiology
|
July 20, 2002
The role of transcranial motor evoked potentials in predicting neurologic and histopathologic outcome after experimental spinal cord ischemia
Jeroen Lips, Peter de Haan, Steven W de Jager, et al.
Journal of Neurosurgical Anesthesiology
|
January 5, 2002
Peri-ischemic aminoguanidine fails to ameliorate neurologic and histopathologic outcome after transient spinal cord ischemia
Jeroen Lips, Steven W de Jager, Peter de Haan, et al.
Diabetologia
|
March 15, 2006
Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002
C Herder, J Baumert, B Thorand, et al.
Journal of Neuroimmunology
|
August 24, 2015
Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy
L Vlam, M Stam, W de Jager, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 25, 2011
Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes
A A Verrijn Stuart, H S Schipper, I Tasdelen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 24, 2014
Correlation of CXCL10, tumor necrosis factor receptor type II, and galectin 9 with disease activity in juvenile dermatomyositis
F Bellutti Enders, F van Wijk, R Scholman, et al.
Page
of 9